Liver Diseases Treatment Market In-depth Analysis and Growth

Liver Diseases Treatment Market to 2025 - Global Analysis and Forecasts by Diseases (Cirrhosis, Hepatitis, Cancer and Other Diseases), Imaging Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Other Modalities) and Geography

Publication Month : Sep 2018

  • Report Code : TIPMD00002089
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 115
Inquire Before Buy

PRICING

$4550

$2730

The liver diseases treatment market is projected to reach US$ US$ 4,883.5 million by 2025 from US$ 3,426.8 million in 2017; it is expected to register a CAGR of 4.6% from 2018 to 2025.

Liver is an organ that is situated just below the rib cage and on the right side of the abdomen. As essential function of liver is to carry out digestion of food and ridding off the body from toxic substances. A liver disease can either be inherited or may occur due to various factors such as, viruses or excessive consumption of alcohol. Over the time, damage to the liver results in scarring, a condition known as liver cirrhosis. The condition of liver can be diagnosed by methods such as, blood tests, tissue analysis and imaging tests. The imaging modalities covered in the report include, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound.

The report offers insights and in-depth analysis of the liver diseases treatment market emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the world. It also includes the impact of the COVID-19 pandemic on the market across all the regions. The COVID-19 pandemic has disrupted the socioeconomic conditions of various countries across the world. In the North American region, the US was profoundly affected by the outbreak of the COVID-19 pandemic. COVID-19 has been linked to liver illness in an increasing number of patients. Multiple mechanisms can contribute to COVID19 liver injury, including virus-induced systemic inflammation, hypoxia, hepatic congestion, and drug-induced liver disease. COVID-19 has been associated to hepatic decompensation and liver-related mortality in patients with liver cirrhosis. COVID-19's influence on healthcare resources has had a negative impact on chronic liver disease patient treatment and results. As a result, the treatment, diagnosis, and follow-up of individuals with liver disease has decreased, resulting in negative effects for the healthcare industry over the anticipated period. The market, based on region, is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

Lucrative Regions for Liver Treatment Market

Lucrative Regions for Liver Treatment Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Rising Prevalence of Cardiovascular Diseases (CVDs)

The geriatric population has been increasing rapidly as compared to the young population. As per data published by the United Nations, in 2017, there were an estimated 962 million people aged 60 or over in the world, which comprised of 13 per cent of the global population. The geriatric population is estimated to grow at a rate of 3 per cent per year. At present, Europe has the highest population aged 60 years and above. The ageing population in the world is projected to reach around 1.4 billion in 2030 and 2.1 billion in 2050 and is expected to reach up to 3.1 billion in 2100. Ageing has been linked with the severity and poor diagnosis of various liver diseases such as, alcoholic liver disease, nonalcoholic fatty liver disease, hepatitis C, and liver transplantation. Various structural as well as microscopic changes are seen in a liver while they are ageing. Its ability to metabolize many substances decreases gradually. Hence, the complications of liver disease also are more severe in the elderly. A study reported, an annual mortality rate of 50% among patients older than 60 years, compared to 7% in patients younger than 60. A report by the Centers for Disease Control and Prevention reported the death rates for chronic liver disease and cirrhosis rose 31% among those age 45 to 64 between 2000 and 2015.

Disease-Based Insights

Based on disease, the liver diseases treatment market is segmented into hepatitis, cirrhosis and cancer. In 2017, cancer held the largest market share. There has been a significant increase in the number of liver cancer cases due to hepatitis infections, smoking, over consumption of alcohol, and obesity. The segment is anticipated to grow with a CAGR of 5.2% during the forecast period.

Liver Diseases treatment Market, by Disease – 2017 and 2025

Liver Diseases treatment Market, by Disease – 2017 and 2025
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Imaging Modality-Based Insights

Based on imaging modality, the liver treatment market is segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, Other Imaging Modalities. Computed tomography (CT) segment is anticipated to grow at a CAGR of 4.7% during the forecast period. A CT scan provides accurate information about the size, shape and position of any tumors in the liver or elsewhere in the abdomen, as well as nearby blood vessels. Hence, it is used to identify the location of a tumor, analyze the extent of cancer in the body and also determine whether the disease is responding to treatments.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Liver Diseases Treatment Market: Strategic Insights

liver-treatment-market
Market Size Value inUS$ 3,426.8 Million in 2017
Market Size Value byUS$ 4,883.5 Million by 2025
Growth rateCAGR of 4.6% from 2018-2025
Forecast Period2018-2025
Base Year2018
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

The liver treatment market players adopt organic strategies such as product launch and expansion to expand their footprint and product portfolio worldwide as well as to meet the growing demand.


By Diseases

  • Cirrhosis
  • Hepatitis
  • Cancer
  • Others

By Imaging Modality

  • Static Cold Storage
  • Hypothermic Machine Perfusion
  • Normothermic Machine Perfusion
  • Others

By

Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of APAC
  • Middle East & Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of MEA
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of SCAM

Company Profiles

  • General Electric
  • Koninklijke Philips N.V.
  • Siemens AG
  • CANON MEDICAL SYSTEMS CORPORATION
  • Hitachi, Ltd
  • Elekta AB (pub)
  • Neusoft Corporation
  • Samsung Healthcare
  • BPL Medical Technologies
  • Cura Healthcare          
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Diseases and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

US, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina

The List of Companies

1. General Electric
2. Koninklijke Philips N.V.
3. Siemens AG
4. CANON MEDICAL SYSTEMS CORPORATION
5. Hitachi, Ltd
6. Elekta AB (pub)
7. Neusoft Corporation
8. Samsung Healthcare
9. BPL Medical Technologies
10. Cura Healthcare

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Liver Diseases Treatment Market